Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Singapore
State: Central Region
Zip:
Country: Singapore
Ligature Therapeutics is an early-stage biotechnology company that develops small molecule “protein degrader” therapeutics. Ligature Therapeutics is an early-stage drug discovery company that takes a novel approach towards developing small molecules for targeted protein degradation to treat intractable diseases. Ligature Therapeutics was founded by doctors Alvin Hung, Thomas Keller, and Congbao Kang with initial investment from Lightstone Singapore, a Singapore-focused venture fund founded in 2016 by Lightstone Ventures.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Seed Round | $0 |
Lightstone Ventures Seeds Capital Lightstone Ventures Seeds Capital |
1/2021 | Seed Round | 2 | $6M |
Lightstone Ventures Seeds Capital Lightstone Ventures Seeds Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|